Dr Roger Douglas Mcelmurry, DDS | |
304 S Main St, Bellevue, ID 83313 | |
(208) 788-2006 | |
Not Available |
Full Name | Dr Roger Douglas Mcelmurry |
---|---|
Gender | Male |
Speciality | Dentist - General Practice |
Location | 304 S Main St, Bellevue, Idaho |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1356600639 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
1223G0001X | Dentist - General Practice | D1717 (Idaho) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Roger Douglas Mcelmurry, DDS 304 S Main Street, Bellevue, ID 83313 Ph: (208) 788-2006 | Dr Roger Douglas Mcelmurry, DDS 304 S Main St, Bellevue, ID 83313 Ph: (208) 788-2006 |
News Archive
Hard hit by one of the worst recessions in nearly a century, hundreds of thousands of Californians lost insurance coverage across the state as employers shed jobs and the health plans that came with those jobs, according to a new report from the UCLA Center for Health Policy Research.
Past random good fortune can lull a person into a sense of security when it comes to buying flood insurance or deciding whether to evacuate from a hurricane, according to new research. Studies of both professional risk experts and the general public showed people who had experienced a "near-miss" event related to flooding or a potential hurricane, instead of taking extra precautions when faced with possible future disasters, actually behave less protectively.
Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ: ONCY) today announced that it has submitted an application for Orphan Drug Designation to the U.S. Food and Drug Administration ("FDA") for REOLYSIN® for the treatment of high grade gliomas (HGG) in pediatric patients.
The replacement of animals as test subjects is one step closer to reality with the successful testing of multi-organ "human-on-a-chip" models to recapitulate the 28-day experiments typically used in animals to evaluate the systemic toxicity of drug and cosmetic compounds.
The results of two new Regenstrief Institute trials published in the Journal of the American Geriatrics Society underscore and confirm the need to look to options other than medication to lower the duration or severity of delirium in intensive care unit patients.
› Verified 7 days ago